A carregar...

Clinical outcomes and safety of apatinib monotherapy in the treatment of patients with advanced epithelial ovarian carcinoma who progressed after standard regimens and the analysis of the VEGFR2 polymorphism

The aims of the present study were to investigate the clinical outcomes and safety of apatinib monotherapy in the treatment of patients with advanced epithelial ovarian carcinoma (EOC) who have progressed after standard regimens, and to analyze the vascular endothelial growth factor receptor 2 (VEGF...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Yan, Zhen, Gu, Yuan-Yuan, Hu, Xiao-Di, Zhao, Qun, Kang, Hai-Li, Wang, Miao, Duan, Wei, Guan, Yin
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7400731/
https://ncbi.nlm.nih.gov/pubmed/32782621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11857
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!